MedTrace Logo

Effectiveness of a Weight Management Programme on Diabetes Remission in Obese Patients With Early Diabetes

NCT05762120 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-03-15

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the effectiveness of a weight management programme in primary care in achieving diabetes remission in obese patients with early diabetes.

Potential participants are to attend a screening visit to determine eligibility. Eligible participants will be invited to participate in the trial within 3 months of screening visit. 120 participants will be recruited into the study and randomised into 2 arms: control group (60 participants) or intervention group (60 participants).

Control group: Participants randomised to the control group will receive usual care with their healthcare team.

Intervention group: Participants randomised to the intervention group will be put on a weight management programme with the aim of achieving weight loss of at least 15% body weight or 15kg.

Researchers will compare between control and intervention groups to see if a weight management programme is effective in achieving diabetes remission in obese patients with early diabetes, compared to usual care.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity

Interventions

OTHER

Weight Management Programme

Weight Management Programme which consists of 4 phases: 1. Very low calorie diet 2. Low calorie diet 3. Maintenance phase 4. Continuance phase

Sponsors & Collaborators

  • Khoo Teck Puat Hospital

    collaborator OTHER

  • National Healthcare Group Polyclinics

    lead OTHER_GOV

Principal Investigators

  • Wern Ee Tang · National Healthcare Group Polyclinics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-03
Primary Completion
2024-12-31
Completion
2025-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05762120 on ClinicalTrials.gov